Upon processing tumor proteins, the dendritic cells may then present tumor neo-antigens to the immune system and generate specific CD8+ cytotoxic T cells that will circulate in the body to seek out tumor cells expressing these novel targets [13]. This evidence concerns the gene CD8A and neoplasm.